Key facts
- It has raised $10.0M; the latest was Early Stage VC in Nov 2024.
- Notable investors include Mantis VC, Forerunner Ventures, L Catterton, G9 Ventures, John Legend — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Tally Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Tally Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tally Health
Developer of anti-aging biological products designed to help people live their fullest lives, for as long as possible. The company offers a membership subscription that includes quarterly tests, personalized lifestyle recommendations, and its science-backed longevity supplement for that extra boost, enabling patients to reach their wellness goals.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 20
- Website
- tallyhealth.com/
- Ownership
- Privately Held (backing)
Tally Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tally Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tally Health in its N-PORT filings yet. We sweep new filings monthly.